Nucleic acid-programmable DNA-binding proteins, including nucleic acid base editing factors.
JP7883760B2Inactive Publication Date: 2026-07-02PRESIDENT & FELLOWS OF HARVARD COLLEGE
Patent Information
- Application Number
- JP2022191651
- Authority / Receiving Office
- JP · JP
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2017-08-30
- Filing Date
- 2022-11-30
- Publication Date
- 2026-07-02
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 0007883760000182 
Figure 0007883760000183 
Figure 0007883760000184
Abstract
Some aspects of the present disclosure provide strategies, systems, reagents, methods, and kits that are useful for targeted editing of nucleic acids, including editing a single site in the genome of a cell or subject, for example, in the human genome. [Solution] In some embodiments, fusion proteins between nucleic acid-programmable DNA-binding proteins (napDNAbp), such as Cpf1 or variants thereof, and a nucleic acid editing protein or protein domain, such as a deaminase domain, are provided. In some embodiments, methods for targeted nucleic acid editing are provided. In some embodiments, reagents and kits are provided for creating fusion proteins between targeted nucleic acid editing proteins, such as napDNAbp (e.g., CasX, CasY, Cpf1, C2c1, C2c2, C2c3, and Argonaute), and a nucleic acid editing protein or domain.
Need to check novelty before this filing date? Find Prior Art
Citation Information
Patent Citations
JPP7191388B
Evaluation of CAS9 molecule / guide RNA molecule complexes
WO2016172727A1
Methods and compositions for treating cells for transplant
WO2016196308A1
Nucleobase editors and uses thereof
WO2017070632A2
Incorporation of unnatural amino acids into proteins using base editing
WO2018039438A1